Tablets 20micrograms

  Liothyronine monotherapy for the management of chronic hypothyroidism – primary and secondary care.

 For the treatment of refractory / resistant depression (unlicensed use)

  Liothyronine therapy commenced in the private sector

 For the treatment of acute conditions where thyroid replacement is needed rapidly, for a limited period and/or where a drug with shorter half-life is required

  Add-on treatment for refractory hypothyroidism – existing patient (RED RAG for Pennine only for this indication)

  Add-on treatment for refractory hypothyroidism despite adequate replacement with levothyroxine – new patients (RED RAG for Pennine only for this indication)